Prevention of Hepatocellular Carcinoma Development Associated with Chronic Hepatitis by Anti-Fas Ligand Antibody Therapy

A persistent immune response to hepatitis viruses is a well-recognized risk factor for hepatocellular carcinoma. However, the molecular and cellular basis for the procarcinogenic potential of the immune response is not well defined. Here, using a unique animal model of chronic hepatitis that induces...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamoto, Yasunari, Kaneko, Shuichi, Fan, Hong, Momoi, Takashi, Tsutsui, Hiroko, Nakanishi, Kenji, Kobayashi, Kenichi, Suda, Takashi
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2002
Materias:
Brief Definitive Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194047/
https://www.ncbi.nlm.nih.gov/pubmed/12391022
http://dx.doi.org/10.1084/jem.20020633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194047/
https://www.ncbi.nlm.nih.gov/pubmed/12391022
http://dx.doi.org/10.1084/jem.20020633

Ejemplares similares